Direct Angioplasty In Acute Myocardial Infarction: State of the Art and Current Controversies (Q40430420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585770%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

review article

1 reference

title

Direct angioplasty in acute myocardial infarction. State of the art and current controversies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585770%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Direct Angioplasty In Acute Myocardial Infarction: State of the Art and Current Controversies (English)

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30032-8

coronary balloon angioplasty

25 May 2024

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585770

25 May 2024

2

Topol EJ

2 references

20 September 2017

21 October 2019

M. C. Horrigan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7585770

25 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7585770

25 May 2024

publication date

1 August 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585770%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

https://api.elsevier.com/content/article/PII:S0733865118300328?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30032-8

https://api.elsevier.com/content/article/PII:S0733865118300328?httpAccept=text/plain

25 May 2024

1 reference

https://api.crossref.org/works/10.1016/S0733-8651(18)30032-8

25 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585770%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585770%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585770%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

321-338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585770%20AND%20SRC:MED&resulttype=core&format=json

Management comparison for acute myocardial infarction: direct angioplasty versus sequential thrombolysis-angioplasty

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Failed direct coronary angioplasty for acute myocardial infarction: in-hospital outcome and predictors of death

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Indications, timing, and optimal technique for diagnostic angiography and angioplasty in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Final results from the Primary Angioplasty Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Importance of a patent infarct-related artery for hospital and late survival after direct coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

The spectrum of pathology associated with percutaneous transluminal coronary angioplasty during acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Early mortality of acute myocardial infarction in patients with and without prior coronary revascularization surgery. A Coronary Artery Surgery Study Registry Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Outcome after acute myocardial infarction in patients with prior coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infa

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Direct angioplasty for acute myocardial infarction. A review of outcomes in clinical subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Predictors of success for coronary angioplasty performed for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Emergency angioplasty in acute anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Thrombolytic therapy for acute myocardial infarction. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

The treatment of shock associated with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Mechanism of acute myocardial infarction in patients with prior coronary artery bypass grafting and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Progressive nature of myocardial injury in selected patients with cardiogenic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without the reduction of infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 70 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Intraaortic balloon pumping as the postangioplasty strategy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Eligibility for intravenous thrombolysis in suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Acute intervention during myocardial infarction in patients with prior coronary bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Acute myocardial infarction treated with intracoronary streptokinase: A report of the society for cardiac angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Coronary angioplasty: A treatment option for left ventricular remodeling after myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

A predictive method for estimating the late angiographic results of coronary intervention despite incomplete ascertainment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Successful coronary angioplasty in two patients with cardiogenic shock using the Nimbus Hemopump support device

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Percutaneous support devices for high risk or complicated coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Trickle down thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Emergency percutaneous transluminal coronary angioplasty without thrombolysis as initial therapy in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Emergency coronary angioplasty for acute myocardial infarction. Results from a community hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Therapeutic trials in coronary thrombosis should measure left ventricular function as primary end-point of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Primary angioplasty for acute myocardial infarction in 1,000 consecutive patients. Results in an unselected population and high-risk subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Angioplasty therapy of cardiogenic shock: are randomized trials necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty Registry)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

The frequency and significance of coronary arterial thrombi and other observations in fatal acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Emergency percutaneous cardiopulmonary bypass support in cardiogenic shock from acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Coronary angioplasty in acute myocardial infarction: primary, immediate adjunctive, rescue, or deferred adjunctive approach?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Late restenosis after emergent coronary angioplasty for acute myocardial infarction: comparison with elective coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Thrombolytic therapy for elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Use of direct angioplasty for treatment of patients with acute myocardial infarction in hospitals with and without on-site cardiac surgery. The Myocardial Infarction, Triage, and Intervention Project Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2818%2930032-8

7 January 2021

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7585770%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference